Published on
Jun 20, 2025
Unifying Concern Emerges as FDA Approves Twice-Yearly PrEP to Prevent HIV
Earlier this week, the Food and Drug Administration (FDA) approved what many HIV advocates herald as a groundbreaking prevention tool with the potential to help end the HIV epidemic: Yeztugo (lenacapavir) is a twice-a-year injection, making it the longest- …
Source:
Real Health
-
Pending
